These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 7790319

  • 1. Establishment and characterization of non-small cell lung cancer cell lines resistant to mitomycin C under aerobic conditions.
    Shibata K, Kasahara K, Bando T, Nakatsumi Y, Fujimura M, Tsuruo T, Matsuda T.
    Jpn J Cancer Res; 1995 May; 86(5):460-9. PubMed ID: 7790319
    [Abstract] [Full Text] [Related]

  • 2. Modulation of sensitivity to mitomycin C and a dithiol analogue by tempol in non-small-cell lung cancer cell lines under hypoxia.
    Bando T, Kasahara K, Shibata K, Numata Y, Heki U, Shirasaki H, Iwasa K, Fujimura M, Matsuda T.
    J Cancer Res Clin Oncol; 1996 May; 122(1):21-6. PubMed ID: 8543588
    [Abstract] [Full Text] [Related]

  • 3. DT-diaphorase as a determinant of sensitivity to adriamycin in non-small-cell lung-cancer cell lines.
    Kasahara K, Shibata K, Bando T, Numata Y, Fujimura M, Matsuda T.
    Int J Cancer; 1994 Oct 15; 59(2):204-7. PubMed ID: 7927920
    [Abstract] [Full Text] [Related]

  • 4. Role of dt-diaphorase as a determinant of sensitivity to mitomycin analogs in nonsmall cell lung-cancer cell-lines.
    Bando T, Kasahara K, Shibata K, Nakatsumi Y, Fujimura M, Matsuda T.
    Int J Oncol; 1994 Oct 15; 5(4):819-25. PubMed ID: 21559647
    [Abstract] [Full Text] [Related]

  • 5. Cytotoxicity of a novel indoloquinone eo9 in hypoxic non-small-cell lung-cancer cell-lines.
    Bando T, Kasahara K, Shibata K, Numata Y, Heki U, Shirasaki H, Iwasa K, Fujimura M, Matsuda T.
    Int J Oncol; 1995 Oct 15; 7(4):789-93. PubMed ID: 21552905
    [Abstract] [Full Text] [Related]

  • 6. [DT-diaphorase].
    Mikami K, Shirakusa T, Tsuruo T.
    Gan To Kagaku Ryoho; 1997 Sep 15; 24(11):1606-10. PubMed ID: 9309161
    [Abstract] [Full Text] [Related]

  • 7. Role of sodium pump systems to determine sensitivity to mitomycin C in non-small cell lung cancer cell lines.
    Bando T, Kasahara K, Shibata K, Numata Y, Nakatsumi Y, Fujimura M, Matsuda T.
    Anticancer Res; 1995 Sep 15; 15(3):769-72. PubMed ID: 7645956
    [Abstract] [Full Text] [Related]

  • 8. Reductase enzyme expression across the National Cancer Institute Tumor cell line panel: correlation with sensitivity to mitomycin C and EO9.
    Fitzsimmons SA, Workman P, Grever M, Paull K, Camalier R, Lewis AD.
    J Natl Cancer Inst; 1996 Mar 06; 88(5):259-69. PubMed ID: 8614004
    [Abstract] [Full Text] [Related]

  • 9. The role of NAD(P)H:quinone oxidoreductase in mitomycin C- and porfiromycin-resistant HCT 116 human colon-cancer cells.
    Pan SS, Akman SA, Forrest GL, Hipsher C, Johnson R.
    Cancer Chemother Pharmacol; 1992 Mar 06; 31(1):23-31. PubMed ID: 1458556
    [Abstract] [Full Text] [Related]

  • 10. The importance of DT-diaphorase in mitomycin C resistance in human colon cancer cell lines.
    Lambert PA, Kang Y, Greaves B, Perry RR.
    J Surg Res; 1998 Dec 06; 80(2):177-81. PubMed ID: 9878310
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of novel platinum complexes, inhibitors of topoisomerase I and II in non-small cell lung cancer (NSCLC) sublines resistant to cisplatin.
    Fukuda M, Ohe Y, Kanzawa F, Oka M, Hara K, Saijo N.
    Anticancer Res; 1995 Dec 06; 15(2):393-8. PubMed ID: 7763011
    [Abstract] [Full Text] [Related]

  • 12. Unusually marked hypoxic sensitization to indoloquinone EO9 and mitomycin C in a human colon-tumour cell line that lacks DT-diaphorase activity.
    Plumb JA, Workman P.
    Int J Cancer; 1994 Jan 02; 56(1):134-9. PubMed ID: 8262670
    [Abstract] [Full Text] [Related]

  • 13. Establishment and characterization of cisplatin-resistant sublines of human lung cancer cell lines.
    Hong WS, Saijo N, Sasaki Y, Minato K, Nakano H, Nakagawa K, Fujiwara Y, Nomura K, Twentyman PR.
    Int J Cancer; 1988 Mar 15; 41(3):462-7. PubMed ID: 3346112
    [Abstract] [Full Text] [Related]

  • 14. Isolation and characterization of a mitomycin C-resistant variant of human colon carcinoma HT-29 cells.
    Lee JH, Naito M, Nakajima M, Tsuruo T.
    Cancer Chemother Pharmacol; 1993 Mar 15; 33(3):215-20. PubMed ID: 7505723
    [Abstract] [Full Text] [Related]

  • 15. Relative importance of DT-diaphorase and hypoxia in the bioactivation of EO9 by human lung tumor cell lines.
    Plumb JA, Gerritsen M, Milroy R, Thomson P, Workman P.
    Int J Radiat Oncol Biol Phys; 1994 May 15; 29(2):295-9. PubMed ID: 8195022
    [Abstract] [Full Text] [Related]

  • 16. Enhanced cytotoxicity of bioreductive antitumor agents with dimethyl fumarate in human glioblastoma cells.
    Gu B, DeAngelis LM.
    Anticancer Drugs; 2005 Feb 15; 16(2):167-74. PubMed ID: 15655414
    [Abstract] [Full Text] [Related]

  • 17. Decreased NADPH:cytochrome P-450 reductase activity and impaired drug activation in a mammalian cell line resistant to mitomycin C under aerobic but not hypoxic conditions.
    Hoban PR, Walton MI, Robson CN, Godden J, Stratford IJ, Workman P, Harris AL, Hickson ID.
    Cancer Res; 1990 Aug 01; 50(15):4692-7. PubMed ID: 2114946
    [Abstract] [Full Text] [Related]

  • 18. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines.
    Beall HD, Murphy AM, Siegel D, Hargreaves RH, Butler J, Ross D.
    Mol Pharmacol; 1995 Sep 01; 48(3):499-504. PubMed ID: 7565631
    [Abstract] [Full Text] [Related]

  • 19. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J, Oleschuk CJ, Guziec F, Guziec L, Fiterman DJ, Monterrosa C, Begleiter A.
    Cancer Chemother Pharmacol; 2002 Feb 01; 49(2):101-10. PubMed ID: 11862423
    [Abstract] [Full Text] [Related]

  • 20. Biochemical characterization of a mitomycin C-resistant human bladder cancer cell line.
    Singh SV, Scalamogna D, Xia H, O'Toole S, Roy D, Emerson EO, Gupta V, Zaren HA.
    Int J Cancer; 1996 Mar 15; 65(6):852-7. PubMed ID: 8631603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.